To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.
Find out MoreAGM | 20-Jun-2022 |
EGM | n/a |
GM | n/a |
Trading Announcement | n/a |
Interim Management Statement (IMS) | n/a |
Drilling Report | n/a |
Final Results | 30-Mar-2022 |
Interim Results | 15-Sep-2022 |
Q1 Results | n/a |
Q2 Results | n/a |
Q3 Results | n/a |
Q4 Results | n/a |
Annual Report | 30-Mar-2022 |
Interim Ex-Dividend Date | n/a |
Interim Dividend Payment Date | n/a |
Final Ex-Dividend Date | n/a |
Final Dividend Payment Date | n/a |
Quarterly Ex-Dividend Date | n/a |
Quarterly Payment Date | n/a |
Special Ex-Dividend Date | n/a |
Special Dividend Payment Date | n/a |